RMTG

Investor Relations

With a commitment to pushing the boundaries of science and medicine, Regenerative Medical Technology Group Inc. has achieved significant milestones in harnessing the potential of stem cells for therapeutic applications. The company's cutting-edge research and development initiatives have led to the discovery of novel approaches to regenerative medicine, offering what the Company believes is new hope to patients around the world.

News & Events

Regenerative Medicine Technology Group

At the head of regenerative medicine's global landscape stands a pioneering stem cell company, revolutionizing research, clinical applications, and patenting treatments worldwide. With a commitment to excellence, we lead the charge in developing cutting-edge products and technologies that push the boundaries of medical possibility. Our world-class stem cell products, meticulously crafted in state-of-the-art laboratories, offer transformative solutions for a myriad of ailments, promising hope to patients and clinicians alike.

Beyond our groundbreaking innovations, the company extends its influence by providing top-tier training for physicians, ensuring that the next generation of medical professionals are equipped with the knowledge and skills to advance regenerative medicine. Through our unwavering dedication to advancement and innovation, this company continues to shape the future of regenerative medicine on a global scale.

Our Companies

Stock Information

Review historical and real-time stock performance with this link to an interactive chart, providing valuable insights for informed investment decisions.

Real Time Data

Get XBRL Data

Executive Leadership

Dave Christensen has over 30 years’ experience in helping companies go from Good to Great. As CEO and EVP of Enterprise Technology Consulting, and a Black Belt in Lean Six Sigma, with a unique specialty in Hoshin Kanri "policy management”, he is a recognized expert in Global Strategy Deployment including exceptional expertise in Technology Development, Global Supply Chain, PCI Payments, POS Systems and Security, Logistics, Freight, Distribution, Inventory, MRO, Service Repairs, CRM, Customer Service and Call Centers. He has had several “C” level positions, has been involved with some of the biggest M&A’s, and successfully completed an IPO with a NASDAQ launch.

David Christensen, CEO & President

Regenerative Medical Technology Group Inc.

About Regenerative Medical Technology Group

Leadership in Regenerative Medicine, Pipeline of Promising Therapies, Strong Financial Performance, and a Commitment to Innovation.

Addressing Global Healthcare Challenges: Regenerative medicine holds the key to addressing some of the most pressing healthcare challenges of our time, including aging populations, chronic diseases, and organ shortages.

Now is the time to invest in the future of healthcare. Join us as we lead the way in regenerative medicine and make a meaningful impact on the lives of patients worldwide.

(800) 956-3935

OTC Markets

433 Plaza Real Suite 275

Boca Raton, FL

Trusted Advisors

Albeck Financial Services, Inc.
11757 Katy Freeway, Suite 1300
Houston, TX 77079

The Doney Law Firm
3651 Lindell Road, Suite D121
Las Vegas, NV 89103

VMCPA Audit Firm
8990 Kirby Drive, Suite 220
Houston, TX 77054

Transhare Transfer Agent

17755 US Highway 19 N, Suite 140

Clearwater, FL 33764

We are an SEC reporting company that trades on the OTC Markets. With millions of people worldwide suffering from a variety of physical and aesthetic conditions and chronic illnesses, RMTG has embarked upon a bold commitment, dedicating our company resources and efforts into an exciting, global growth market of regenerative medicine technologies.